MakeMyTrip IPO: India arm gets SEBI approval to float IPO; check details
MakeMyTrip's India subsidiary, MMT India, received SEBI approval for an IPO, allowing it to proceed with preparations. The IPO will include equity shares sold by MakeMyTrip and its subsidiary, ibibo Group. Proceeds will strengthen MakeMyTrip's cash position and fund growth initiatives. MMT India will remain a subsidiary post-IPO.
How this was made

The 30-second read
Why it matters
Regulatory approval removes a key barrier, likely increasing the parent’s valuation and attracting speculative buying ahead of the IPO.
Market read
First‑time regulatory clearance for a foreign‑listed company's Indian subsidiary IPO, creating a near‑term trading opportunity.
What to watch
Potential regulatory scrutiny on foreign ownership and market appetite for travel‑sector listings amid economic uncertainty.
Background
MakeMyTrip is a Nasdaq‑listed travel booking platform; its India arm operates a large domestic travel marketplace.
Market effects
May boost sentiment for Indian travel and online booking sector as a high‑profile IPO approaches.
Could add to overall foreign‑direct investment inflows into Indian tech companies.
Limited to investors tracking emerging‑market listings; no immediate global market shift.
Counterpoint
If the IPO pricing is too aggressive, the shares could face a post‑listing sell‑off.
Key entities
- CompanyMakeMyTrip Ltd
Parent company listed on Nasdaq (ticker MAK).
- SubsidiaryMakeMyTrip India Ltd
Indian subsidiary seeking to list via IPO.
- RegulatorSEBI
Securities and Exchange Board of India, approved the IPO filing.




